Sanofi Partners With Academic Cooperative Groups To Study Amcenestrant In Breast Cancer

(RTTNews) – Sanofi (SNYNF, SNY) said that it has partnered with academic cooperative groups to initiate a pivotal trial of an oral selective estrogen receptor degrader or SERD in the adjuvant setting.

The academic cooperative groups are the Breast International Group (BIG), the European Organization for Research and Treatment of Cancer (EORTC)…